Basic Information
RNALocate ID: | RLID:11001860 |
RNA Symbol: | hsa-miR-125a-5p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-125a-5p |
RNA ID: | miRBase:MIMAT0000443 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 22211110 |
Tissue/Cell Line: | Breast milk |
Method: | Next-generation RNA sequencing |
The expression profile of selected miRNAs in breast milk exosomes. Originally published in Int J Biol Sci. Zhou Q, et al, 2012. Reproduced under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) |
|
Description: | Distribution and characterization of miRNAs in breast milk exosomes. (A) Distribution of pre-miRNAs. Out of 1,424 pre-miRNAs deposited in miRBase 17.0 (blue circle), 87 (6.11%) pre-miRNAs have been designated as immune-related pre-miRNAs based on annotation in the Pathway Central database (SABiosciences, MD, USA). Immune-related pre-miRNAs (59 of 452, 13.05%) are enriched in breast milk exosomes (red circle). χ2 test: Number of immune-related miRNAs and others detected in breast milk exosomes compared with the total entries in miRBase 17.0. (B) Top ten most highly expressed unique miRNAs. Plot of the unique miRNAs (starting from the miRNA with the highest counts, x-axis) versus their cumulative % of the total counts from 602 unique miRNAs detected in breast milk exosomes for each small RNA library. Values are means ± s.d. The dashed horizontal line at 62.3% represents the level of the top ten unique miRNAs and the % of individual miRNAs is marked by the gray line. (C-E) The expression profile of selected miRNAs in breast milk exosomes. (C) 59 immune-related pre-miRNAs; (D) miR-17-92 cluster and paralogous clusters, and (E) ten well-characterized tissue-specific pre-miRNAs. Data are collected from Figure 2. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001809 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001810 | Mitochondrion | Myotube | 27396686 |
RLID:01001811 | Mitochondrion | Skeletal muscle cells | 27563705 |
RLID:01001812 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01001813 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01001814 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001815 | Nucleolus | HeLa cells | 23940654 |
RLID:01001816 | Nucleolus | Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:11001858 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
RLID:11001859 | Exosome | Renal cancer cells | 21670082 |
RLID:11001861 | Exosome | Brain tissue | 23382797 |
RLID:11001862 | Exosome | Plasma | 23663360 |
RLID:11001863 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11001864 | Extracellular vesicle | HEK-293T cells | 22849433 |
RLID:11001865 | Microvesicle | Seminal plasma | 23539611 |
RLID:11001866 | Microvesicle | Follicular fluid | 23666971 |
RLID:11001867 | Microvesicle | Hepatoma cells | 23771658 |
RLID:11001868 | Microvesicle | Serum | 24797360 |
RLID-D:11000091 | Exosome | Blood|Breast milk|Endothelial cells|Epithelial cells|Mast cells|Seminal fluid|Tongue tissue | |
RLID-D:11000371 | Microvesicle | Blood|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-125a-5p | Diffuse large b cell lymphoma | MNDR-E-MI-07005 |
MNDR | hsa-miR-125a-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-07006 |
MNDR | hsa-miR-125a-5p | Oral squamous cell carcinoma | MNDR-E-MI-07007 |
MNDR | hsa-miR-125a-5p | Large cell neuroendocrine cancer | MNDR-E-MI-07008 |
MNDR | hsa-miR-125a-5p | Medulloblastoma | MNDR-E-MI-07009 |
MNDR | hsa-miR-125a-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-07010 |
MNDR | hsa-miR-125a-5p | Lymphoma | MNDR-E-MI-07011 |
MNDR | hsa-miR-125a-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-07012 |
MNDR | hsa-miR-125a-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-07013 |
MNDR | hsa-miR-125a-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-07014 |
MNDR | hsa-miR-125a-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-07015 |
MNDR | hsa-miR-125a-5p | Her2-receptor positive breast cancer | MNDR-E-MI-07016 |
MNDR | hsa-miR-125a-5p | Breast cancer luminal | MNDR-E-MI-07017 |
MNDR | hsa-miR-125a-5p | Anencephaly | MNDR-E-MI-07018 |
MNDR | hsa-miR-125a-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-07019 |
MNDR | hsa-miR-125a-5p | Prostate cancer | MNDR-E-MI-07020 |
MNDR | hsa-miR-125a-5p | Prostate carcinoma | MNDR-E-MI-07021 |
MNDR | hsa-miR-125a-5p | Gastric cancer | MNDR-E-MI-07022 |
MNDR | hsa-miR-125a-5p | Alzheimer disease | MNDR-E-MI-07023 |
MNDR | hsa-miR-125a-5p | Intracranial aneurysm | MNDR-E-MI-07024 |
MNDR | hsa-miR-125a-5p | Esophageal carcinoma | MNDR-E-MI-07025 |
MNDR | hsa-miR-125a-5p | Dysautonomia familial | MNDR-E-MI-07026 |
MNDR | hsa-miR-125a-5p | Leukemia | MNDR-E-MI-07027 |
MNDR | hsa-miR-125a-5p | Acute leukemia | MNDR-E-MI-07028 |
MNDR | hsa-miR-125a-5p | Cardiovascular disease | MNDR-E-MI-07029 |
MNDR | hsa-miR-125a-5p | Lung cancer | MNDR-E-MI-07030 |
MNDR | hsa-miR-125a-5p | Parkinson disease | MNDR-E-MI-07031 |
MNDR | hsa-miR-125a-5p | Basal-like breast cancer | MNDR-E-MI-07032 |
MNDR | hsa-miR-125a-5p | Vascular diseases | MNDR-E-MI-07033 |
MNDR | hsa-miR-125a-5p | Thyroid cancer | MNDR-E-MI-07034 |
MNDR | hsa-miR-125a-5p | Pancreatic cancer | MNDR-E-MI-07035 |
MNDR | hsa-miR-125a-5p | Malignant melanoma | MNDR-E-MI-07036 |
MNDR | hsa-miR-125a-5p | Rectum adenocarcinoma | MNDR-E-MI-07037 |
MNDR | hsa-miR-125a-5p | Colon cancer | MNDR-E-MI-07038 |
MNDR | hsa-miR-125a-5p | Colon adenocarcinoma | MNDR-E-MI-07039 |
MNDR | hsa-miR-125a-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-07040 |
MNDR | hsa-miR-125a-5p | Ovarian cancer | MNDR-E-MI-07041 |
MNDR | hsa-miR-125a-5p | Basal cell carcinoma | MNDR-E-MI-07042 |
MNDR | hsa-miR-125a-5p | Prostate adenocarcinoma | MNDR-E-MI-07043 |
MNDR | hsa-miR-125a-5p | Carcinoma ductal breast | MNDR-E-MI-07044 |
MNDR | hsa-miR-125a-5p | Glioblastoma | MNDR-E-MI-07045 |
MNDR | hsa-miR-125a-5p | Astrocytoma | MNDR-E-MI-07046 |
MNDR | hsa-miR-125a-5p | Glioma | MNDR-E-MI-07047 |
MNDR | hsa-miR-125a-5p | Chronic obstructive pulmonary disease | MNDR-E-MI-07048 |
MNDR | hsa-miR-125a-5p | Chordoma | MNDR-E-MI-07049 |
MNDR | hsa-miR-125a-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-07050 |
MNDR | hsa-miR-125a-5p | Osteosarcoma | MNDR-E-MI-07051 |
MNDR | hsa-miR-125a-5p | Carotid artery thrombosis | MNDR-E-MI-07052 |
MNDR | hsa-miR-125a-5p | Inclusion body myositis | MNDR-E-MI-07053 |
MNDR | hsa-miR-125a-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-07054 |
MNDR | hsa-miR-125a-5p | Meningioma | MNDR-E-MI-07055 |
MNDR | hsa-miR-125a-5p | Uterine cancer | MNDR-E-MI-07056 |
MNDR | hsa-miR-125a-5p | Cervical adenocarcinoma | MNDR-E-MI-07057 |
MNDR | hsa-miR-125a-5p | Gastric adenocarcinoma | MNDR-E-MI-07058 |
MNDR | hsa-miR-125a-5p | Cervical squamous cell carcinoma | MNDR-E-MI-07059 |
MNDR | hsa-miR-125a-5p | Lung squamous cell carcinoma | MNDR-E-MI-07060 |
MNDR | hsa-miR-125a-5p | Carcinoma lung non-small-cell | MNDR-E-MI-07061 |
MNDR | hsa-miR-125a-5p | Lung adenocarcinoma | MNDR-E-MI-07062 |
MNDR | hsa-miR-125a-5p | Adrenocortical cancer | MNDR-E-MI-07063 |
MNDR | hsa-miR-125a-5p | Thyroid carcinoma | MNDR-E-MI-07064 |
MNDR | hsa-miR-125a-5p | Bladder urothelial carcinoma | MNDR-E-MI-07065 |
MNDR | hsa-miR-125a-5p | Pancreatic adenocarcinoma | MNDR-E-MI-07066 |
MNDR | hsa-miR-125a-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-07067 |
MNDR | hsa-miR-125a-5p | Carcinoma renal cell | MNDR-E-MI-07068 |
MNDR | hsa-miR-125a-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-07069 |
MNDR | hsa-miR-125a-5p | Clear cell renal cell carcinoma | MNDR-E-MI-07070 |
MNDR | hsa-miR-125a-5p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-07071 |
MNDR | hsa-miR-125a-5p | Cholangiocarcinoma | MNDR-E-MI-07072 |
MNDR | hsa-miR-125a-5p | Thyroid gland disease | MNDR-E-MI-07073 |
MNDR | hsa-miR-125a-5p | Esophageal cancer | MNDR-E-MI-07074 |
MNDR | hsa-miR-125a-5p | Liver cirrhosis | MNDR-E-MI-07075 |
MNDR | hsa-miR-125a-5p | Encephalopathy bovine spongiform | MNDR-E-MI-07076 |
MNDR | hsa-miR-125a-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-07077 |
MNDR | hsa-miR-125a-5p | T acute lymphoblastic leukemia | MNDR-E-MI-07078 |
MNDR | hsa-miR-125a-5p | Acute t cell leukemia | MNDR-E-MI-07079 |
MNDR | hsa-miR-125a-5p | Fibromyalgia | MNDR-E-MI-07080 |
MNDR | hsa-miR-125a-5p | Breast invasive carcinoma | MNDR-E-MI-07081 |
MNDR | hsa-miR-125a-5p | Cerebrovascular disease | MNDR-E-MI-07082 |
MNDR | hsa-miR-125a-5p | Juvenile rheumatoid arthritis | MNDR-E-MI-07083 |
MNDR | hsa-miR-125a-5p | Hepatocellular carcinoma | MNDR-E-MI-07084 |
MNDR | hsa-miR-125a-5p | Rheumatoid arthritis | MNDR-E-MI-07085 |
MNDR | hsa-miR-125a-5p | Malignant pleural mesothelioma | MNDR-E-MI-07086 |
MNDR | hsa-miR-125a-5p | Retinoblastoma | MNDR-E-MI-07087 |
MNDR | hsa-miR-125a-5p | Neuroblastoma | MNDR-E-MI-07088 |
MNDR | hsa-miR-125a-5p | Barrett's adenocarcinoma | MNDR-E-MI-07089 |
MNDR | hsa-miR-125a-5p | Hodgkin lymphoma | MNDR-E-MI-07090 |
MNDR | hsa-miR-125a-5p | Crohn disease | MNDR-E-MI-07091 |
MNDR | hsa-miR-125a-5p | Tonsil cancer | MNDR-E-MI-07092 |
MNDR | hsa-miR-125a-5p | Systemic lupus erythematosus | MNDR-E-MI-07093 |
MNDR | hsa-miR-125a-5p | Acute myeloid leukemia | MNDR-E-MI-07094 |
MNDR | hsa-miR-125a-5p | Colorectal cancer | MNDR-E-MI-07095 |
MNDR | hsa-miR-125a-5p | Nasopharynx carcinoma | MNDR-E-MI-07096 |
MNDR | hsa-miR-125a-5p | Type 2 diabetes mellitus | MNDR-E-MI-07097 |
MNDR | hsa-miR-125a-5p | Multiple myeloma | MNDR-E-MI-07098 |
MNDR | hsa-miR-125a-5p | Recurrent pregnancy loss | MNDR-E-MI-07099 |
MNDR | hsa-miR-125a-5p | Ovarian epithelial cancer | MNDR-E-MI-07100 |
MNDR | hsa-miR-125a-5p | Ependymoma | MNDR-E-MI-07101 |
MNDR | hsa-miR-125a-5p | Nasopharyngeal cancer | MNDR-E-MI-07102 |
MNDR | hsa-miR-125a-5p | Sleep deprivation | MNDR-E-MI-07103 |
MNDR | hsa-miR-125a-5p | Wounds and injuries | MNDR-E-MI-07104 |
MNDR | hsa-miR-125a-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-07105 |
MNDR | hsa-miR-125a-5p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-07106 |
MNDR | hsa-miR-125a-5p | Pancreatitis chronic | MNDR-E-MI-07107 |
MNDR | hsa-miR-125a-5p | Stroke lacunar | MNDR-E-MI-07108 |
MNDR | hsa-miR-125a-5p | Barrett's carcinogenesis | MNDR-E-MI-07109 |
MNDR | hsa-miR-125a-5p | Duke C | MNDR-E-MI-07110 |
MNDR | hsa-miR-125a-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-07111 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ABL2 | Homo sapiens | RR00027148 |
TOP